Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Blood (2011) 117 (22): 5835–5849.

https://doi.org/10.1182/blood-2010-11-316745

Published: 2011

Includes: Supplemental data

Journal Articles

Significantly Elevated Vitamin B 12 Levels in Autoimmune Lymphoproliferative Syndrome (ALPS), a Rare Lymphoproliferative Disorder with Apoptosis Defect

Raffick AR Bowen, MLT, PhD, DClChem, FCACB, DABCC, Janet K Dale, RN, MPH, Margaret Brown, BSc, Steven K Drake, PhD, Tarsilla Moura, Kennichi Dowdell, PhD, Alan T Remaley, MD, PhD, Thomas A Fleisher, MD, Glen L Hortin, MD, PhD, Ebba Nexo, MD, Stephen E Straus, MD, V. Koneti Rao, MD, FRCPA

Blood (2008) 112 (11): 4898.

https://doi.org/10.1182/blood.V112.11.4898.4898

Published: 2008

Journal Articles

Hydroxychloroquine Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Kennichi C. Dowdell, Ph.D., Lesley Pesnicak, BS, Lilia Bi, Ph.D., Victoria Hoffmann, DVM, V. Koneti Rao, MD, Stephen E. Straus, MD

Blood (2007) 110 (11): 1385.

https://doi.org/10.1182/blood.V110.11.1385.1385

Published: 2007

Journal Articles

Role of Somatic Fas Mutations in the Pathogenesis of Autoimmune Lymphoproliferative Syndrome (ALPS).

Kennichi C. Dowdell, PhD, Julie Niemela, BS, MT(ASCP), Janet K. Dale, RN, MPH, Jennifer Puck, MD, V. Koneti Rao, MD, Thomas Fleisher, MD, Stephen E. Straus, MD

Blood (2006) 108 (11): 3900.

https://doi.org/10.1182/blood.V108.11.3900.3900

Published: 2006

Journal Articles

Valproic Acid (VPA), a Histone Deacetylase (HDAC) Inhibitor, Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Kennichi C. Dowdell, PhD, Lesley Pesnicak, BS, Victoria Hoffman, DVM, Kenneth Steadman, BS, Mark Ruddel, MS, V. Koneti Rao, MD, Stephen E. Straus, MD

Blood (2006) 108 (11): 2497.

https://doi.org/10.1182/blood.V108.11.2497.2497

Published: 2006

Journal Articles

Pyrimethamine Does Not Diminish Lymphoproliferation in MRL/lpr−/− Mice and Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

V. Koneti Rao, MD, Kennichi C. Dowdell, PhD, Faith Dugan, RN, Janet K. Dale, RN, MPH, Lesley Pesnicak, Lilia Bi, PhD, Scott Penzak, Pharm D, Nilo A. Avila, MD, Thomas A. Fleisher, MD, Jennifer M. Puck, MD, Stephen E. Straus, MD

Blood (2005) 106 (11): 2396.

https://doi.org/10.1182/blood.V106.11.2396.2396

Published: 2005

Journal Articles

Whole-Body Positron Emission Tomography (PET) Using 2- 18 Fluoro-2-Deoxy-D-Glucose (FDG) for Monitoring Lymphadenopathy in Autoimmune Lymphoproliferative Syndrome (ALPS).

V. Koneti Rao, MD, Jorge A. Carrasquillo, MD, Janet K. Dale, RN, MPH, Stephen Bacharach, PhD, Millie Whatley, RNMT, Faith Dugan, RN, Jean Tretler, RN, Elaine S. Jaffe, MD, Wyndham Wilson, MD, Nilo Avila, MD, Stephen E. Straus, MD

Blood (2004) 104 (11): 3850.

https://doi.org/10.1182/blood.V104.11.3850.3850

Published: 2004

Journal Articles

Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation

Harutaka Katano, Mir A. Ali, Andriani C. Patera, Marta Catalfamo, Elaine S. Jaffe, Hiroshi Kimura, Janet K. Dale, Stephen E. Straus, Jeffrey I. Cohen

Blood (2004) 103 (4): 1244–1252.

https://doi.org/10.1182/blood-2003-06-2171

Published: 2004

Journal Articles

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome

Jack J. H. Bleesing, Margaret R. Brown, Stephen E. Straus, Janet K. Dale, Richard M. Siegel, Michele Johnson, Michael J. Lenardo, Jennifer M. Puck, Thomas A. Fleisher

Blood (2001) 98 (8): 2466–2473.

https://doi.org/10.1182/blood.V98.8.2466

Published: 2001

Journal Articles

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

Blood (2001) 98 (1): 194–200.

https://doi.org/10.1182/blood.V98.1.194

Published: 2001

Journal Articles

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression

Uri Lopatin, Xu Yao, Richard K. Williams, Jack J. H. Bleesing, Janet K. Dale, David Wong, Julie Teruya-Feldstein, Scott Fritz, Matthew R. Morrow, Ivan Fuss, Michael C. Sneller, Mark Raffeld, Thomas A. Fleisher, Jennifer M. Puck, Warren Strober, Elaine S. Jaffe, Stephen E. Straus

Blood (2001) 97 (10): 3161–3170.

https://doi.org/10.1182/blood.V97.10.3161

Published: 2001

Journal Articles

Fulminant EBV + T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome

Leticia Quintanilla-Martinez, Shimareet Kumar, Falko Fend, Edgardo Reyes, Julie Teruya-Feldstein, Douglas W. Kingma, Lynn Sorbara, Mark Raffeld, Stephen E. Straus, Elaine S. Jaffe

Blood (2000) 96 (2): 443–451.

https://doi.org/10.1182/blood.V96.2.443

Published: 2000

Journal Articles

Clinical, Immunologic, and Genetic Features of an Autoimmune Lymphoproliferative Syndrome Associated With Abnormal Lymphocyte Apoptosis

Michael C. Sneller, Jin Wang, Janet K. Dale, Warren Strober, Lindsay A. Middelton, Youngnim Choi, Thomas A. Fleisher, Megan S. Lim, Elaine S. Jaffe, Jennifer M. Puck, Michael J. Lenardo, Stephen E. Straus

Blood (1997) 89 (4): 1341–1348.

https://doi.org/10.1182/blood.V89.4.1341

Published: 1997

NARROW

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Significantly Elevated Vitamin B 12 Levels in Autoimmune Lymphoproliferative Syndrome (ALPS), a Rare Lymphoproliferative Disorder with Apoptosis Defect

Hydroxychloroquine Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Role of Somatic Fas Mutations in the Pathogenesis of Autoimmune Lymphoproliferative Syndrome (ALPS).

Valproic Acid (VPA), a Histone Deacetylase (HDAC) Inhibitor, Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).

Pyrimethamine Does Not Diminish Lymphoproliferation in MRL/lpr−/− Mice and Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

Whole-Body Positron Emission Tomography (PET) Using 2- 18 Fluoro-2-Deoxy-D-Glucose (FDG) for Monitoring Lymphadenopathy in Autoimmune Lymphoproliferative Syndrome (ALPS).

Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression

Fulminant EBV + T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome

Clinical, Immunologic, and Genetic Features of an Autoimmune Lymphoproliferative Syndrome Associated With Abnormal Lymphocyte Apoptosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only